Nutriband (NASDAQ:NTRBW – Get Free Report) is expected to release its results before the market opens on Wednesday, September 30th. Analysts expect the company to post earnings of ($1.89) per share and revenue of $0.7650 million for the quarter.
Nutriband Price Performance
NASDAQ NTRBW opened at $1.31 on Monday. Nutriband has a 52 week low of $0.17 and a 52 week high of $2.99. The stock’s 50-day moving average price is $0.60 and its 200-day moving average price is $0.96.
Nutriband Company Profile
Nutriband Inc is a medical technology company focused on the development, manufacturing and commercialization of transdermal and topical delivery systems. Its products are designed to deliver active pharmaceutical ingredients, nutraceuticals and other compounds through the skin using adhesive patches.
The company’s product portfolio includes consumer wellness patches and pharmaceutical delivery technologies. Nutriband has also developed Aversa, an abuse-deterrent transdermal system intended to help reduce the risk of drug extraction and misuse from certain prescription patches, including fentanyl patches.
Read More
- Five stocks we like better than Nutriband
- Data Centers Got the AI Hype—But Office REITs May Get the Rent Hikes
- 2 Cybersecurity Stocks Breaking Out as AI Continues to Be a Tailwind
- 3 More AI Infrastructure Plays Beyond the Big Names
- CAVA Stock Slips: Sector Fear or Valuation Reality?
Receive News & Ratings for Nutriband Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutriband and related companies with MarketBeat.com's FREE daily email newsletter.
